Loading...
New

Peripheral Artery Disease Market by Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Peripheral Accessories): Global Opportunity Analysis and Industry Forecast, 2020–2027

A03968
Pages: 229
Jul 2020 | 5367 Views
 
Author(s) : Ravi Telugunta, Apoorva Srivastava , OnkarSumant
Tables: 72
Charts: 66
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Peripheral Artery Disease Market

Request Now !

The peripheral artery disease market accounted for $3,524.77 million in 2019, and is expected to reach $5,715.12 million by 2027, registering a CAGR of 8.5% from 2020 to 2027.

Production interruptions of PAD devices and delays in procedures from hospitals due to COVID-19 pandemic is expected to effect the growth of Peripheral Artery Disease Market.

Peripheral artery disease (PAD) is a common circulatory problem in which narrowed arteries reduce blood flow to limbs. PAD usually affects arteries in the legs and sometimes affect the arteries that carry blood from heart to head, arms, kidneys, and stomach. It is caused by deposition of fats (plaques) in the artery walls, which reduces the blood flow to organs, limbs, and head. 

Peripheral-Artery-Disease-Market-2020-2027

Get more information on this report : Request Sample Pages

 

Factors such as rapid growth in geriatric population and subsequent increase in prevalence of peripheral artery diseases, along with increase inproduct approvals drive growth of the peripheral artery disease market. In addition, rise incases of diabetes drive growth of the peripheral artery disease market. However, the issue of restenosis (reoccurrence of peripheral artery disease even after the treatment) impedes the market growth.In addition, constantly changing lifestyle habits such as unhealthy dietary habits, excessive alcohol consumption, obesity, smoking, and lack of physical activity also make individuals more susceptible to peripheral artery disease and thus, drive the market growth. For instance, according to the American Heart Association, peripheral artery disease (PAD) affects over 8.5 million Americans yearly.

Most markets are dropping down,owing to the outbreak, including the peripheral artery disease market. The peripheral artery disease market is negatively impacted by the pandemic as most countries adopted lockdown to combat the pandemic. In addition, the American College of Surgeons (ACS) has recently developed guidelines for triage of vascular surgery patients, suggesting that non-emergency peripheral vascular procedures such as endovascular therapy for claudication should be postponed. Moreover, in regions severely affected by COVID-19, vascular procedures have been reduced to life or limb salvaging cases, owing to new government directives or hospital guidelines.All these factors are anticipated to impact the peripheral artery disease market as well in the future.

Peripheral Artery Disease Market
By Type

Your browser does not support the canvas element.

Plaque Modification Devices is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Region wise, the peripheral arterial disease market is segmented in North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in 2019. The dominance is majorly attributed to high adoption rates of minimally invasive surgeries and higher healthcare expenditurein the region. Moreover, Europe accounted for the second largest market for peripheral arterial disease. In addition, rise in aging population is also expected to boost the demand for peripheral arterial devices in the forecast period. 

Peripheral Artery Disease Market
By Region

2027
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 9.4% during 2020-2027.

Get more information on this report : Request Sample Pages

Some other drivers in the include rise indemand for minimally invasive endovascular procedures, owing to their shorter recovery time, lesser scaring, and lesser chances of post-surgery infections. In addition, growth inprevalence of disease-causing lifestyle and eating habits such as high consumption of alcohols, tobacco products, and smoking cigarettes is expected to boost peripheral vascular devices demand by triggering incidence rates of cardiac arrest, blood clotting, and other vascular diseases.

Rise in prevalence of population suffering from cardiac diseases is expected to positively affect growth of the peripheral artery disease market. Moreover, increase in initiatives undertaken by authorities and governments to improve healthcare systems and spread awareness regarding benefits of PAD devices are also expected to increase growth of the market during the forecast period.

Peripheral Arterial Disease market Segmentation

The peripheral artery disease market is segmented on the basis of type and region. On the basis of type, it is categorized into peripheral angioplasty balloons, peripheral stents, peripheral catheters, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, France, Spain, Italy, and rest of Europe), Asia-Pacific (Japan, China, India, Australia,and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Segment review

On the basis of type,the peripheral stents segment dominated the global market in 2019, and is anticipated to continue this trend throughout the forecast period, due tothe technological advancement in stents such as drug eluting and drug coated stents. Furthermore, growing access to peripheral stents in angioplasty and traditional open surgery, is expected to accelerate the growth of global market and hence are projected to be in demand throughout the forecast period.

Snapshot of Asia-PacificPeripheral Arterial DiseaseMarket

Asia-Pacific is anticipated to be the most lucrative market for peripheral arterial disease. Major factors that attribute toward the fastest growth of this region is presence of large patient pool with unmet medical needs. In addition, growth in healthcare scenario in Asian countries, coupled with growth in GDP and government initiativesare expected to boost growth ofthe peripheral arterial disease market. Brazil have a significant potential for growth, owing to developing medical infrastructure, high disposable income, and risein prevalence of peripheral arterial diseases in the region. Furthermore, increase in population coupled with high growing geriatric population provide lucrative opportunities for key players operating in the PAD market. In addition, rise in healthcare expenditure and developing guidelines are expected to propelthe market growth in the region.

The key companies operating in the peripheral artery disease market include Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Cardinal Health, Inc., Becton, Dickinson and Company, Terumo Corporation, Koninklijke Philips N.V, AngioDynamics, Inc., BIOTRONIK, and B. Braun Melsungen AG.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the peripheral artery disease market along with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2019 to 2027, which is expected to enable stakeholders to capitalize on prevailing peripheral artery disease market opportunities.
  • The key market players and their strategies have been analyzed to understand the competitive outlook of the peripheral artery disease market.

Key Market Segments

By Type

  • Peripheral Angioplasty Balloons
    • Old/Normal Balloons
    • Cutting and Scoring Balloons
    • Drug-Coated Balloons
  • Peripheral Stents
    • Self-expandable
    • Balloon-expandable
    • Covered
    • Drug-eluting Stents
  • Peripheral Catheters
    • Angiography Catheters
    • Guiding Catheters
  • Inferior Vena Cava (IVC) Filters
    • Permanent Filters
    • Retrievable Filters
  • Plaque Modification Devices
    • Thrombectomy Devices
      • Mechanical Thrombectomy Devices
      • Aspiration Thrombectomy Devices
      • Rheolytic Thrombectomy Devices
    • Atherectomy Devices
  • Hemodynamic Flow Alteration Devices
    • Embolic Protection Devices
    • Chronic Total Occlusion Devices
  • Peripheral Accessories
    • Vascular Closure Devices
    • Introducer Sheaths
    • Guidewires
  • Balloon Inflation Devices

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments

1.2.1.List of key players profiled in the report

1.3.Research methodology

1.3.1.Primary research
1.3.2.Secondary research
1.3.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Top winning strategies, 2019
3.3.Top player positioning

3.3.1.Top investment pockets

3.4.Key forces shaping peripheral artery disease industry/market

3.4.1.Drivers

3.4.1.1.Growth in geriatric population and increase in prevalence of peripheral artery disease
3.4.1.2.Introduction of advanced interventional products
3.4.1.3.Improvement of healthcare infrastructure in developing countries
3.4.1.4.Improved insurance and reimbursement policies

3.4.2.Restraints

3.4.2.1.Restenosis
3.4.2.2.Stringent approval process for stents

3.4.3.Opportunity

3.4.3.1.Market opportunities in developing countries

3.4.4.Impact Analysis

3.5.COVID-19 impact on the market

CHAPTER 4:PERIPHERAL ARTERY DISEASE MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast, by type

4.2.Peripheral Angioplasty Balloons

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Peripheral angioplasty balloons, by type

4.2.4.1.Market size and forecast
4.2.4.2.Old/normal balloons, market size and forecast
4.2.4.3.Cutting & scoring balloons, market size and forecast
4.2.4.4.Drug-coated balloons, market size and forecast

4.3.Peripheral Stents

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.3.4.Peripheral stent, by type

4.3.4.1.Market size and forecast
4.3.4.2.Self-expandable, market size and forecast
4.3.4.3.Balloon-expandable, market size and forecast
4.3.4.4.Covered stents, market size and forecast
4.3.4.5.Drug-eluting stents, market size and forecast

4.4.Peripheral Catheters

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.4.4.Peripheral catheters, by type

4.4.4.1.Market size and forecast
4.4.4.2.Angiography catheters, market size and forecast
4.4.4.3.Guiding catheters, market size and forecast

4.5.Inferior Vena Cava (IVC) Filters

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
4.5.4.Inferior vena cava (IVC) filters, by type

4.5.4.1.Market size and forecast
4.5.4.2.Permanent filters, market size and forecast
4.5.4.3.Retrievable filters, market size and forecast

4.6.Plaque Modification Devices

4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis, by country
4.6.4.Plaque modification devices, by type

4.6.4.1.Market size and forecast
4.6.4.2.Thrombectomy devices, market size and forecast
4.6.4.3.Thrombectomy devices, By type
4.6.4.4.Thrombectomy devices, market size and forecast, by type

4.6.4.4.1.Mechanical thrombectomy devices, market size and forecast
4.6.4.4.2.Aspiration thrombectomy devices, market size and forecast
4.6.4.4.3.Rheolytic thrombectomy devices, market size and forecast

4.6.4.5.Atherectomy devices, market size and forecast

4.7.Hemodynamic Flow Alteration Devices

4.7.1.Key market trends, growth factors, and opportunities
4.7.2.Market size and forecast, by region
4.7.3.Market analysis, by country
4.7.4.Hemodynamic flow alteration devices, By type

4.7.4.1.Market size and forecast
4.7.4.2.Embolic protection devices, market size and forecast
4.7.4.3.Chronic total occlusion devices, market size and forecast

4.8.Peripheral Accessories

4.8.1.Key market trends, growth factors, and opportunities
4.8.2.Market size and forecast, by region
4.8.3.Market analysis, by country
4.8.4.Peripheral Accessories, By type

4.8.4.1.Market size and forecast
4.8.4.2.Peripheral vascular closure devices, market size and forecast
4.8.4.3.Introducer sheaths, market size and forecast
4.8.4.4.Guidewires, market size and forecast
4.8.4.5.Balloon inflation devices, market size and forecast

CHAPTER 5:PERIPHERAL ARTERY DISEASE MARKET, BY REGION

5.1.Overview

5.1.1.Market size and forecast, by region

5.2.North America

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by country
5.2.3.Market size and forecast, by type
5.2.4.U.S.

5.2.5.Canada
5.2.6.Mexico

5.3.Europe

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by country
5.3.3.Market size and forecast, by type
5.3.4.Germany
5.3.5.France
5.3.6.UK
5.3.7.Italy
5.3.8.Spain
5.3.9.Rest of Europe

5.4.Asia-Pacific

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by country
5.4.3.Market size and forecast, by type
5.4.4.Japan
5.4.5.China
5.4.6.India
5.4.7.Australia
5.4.8.Rest of Asia-Pacific

5.5.LAMEA

5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by country
5.5.3.Market size and forecast, by type
5.5.4.Brazil
5.5.5.South Africa
5.5.6.Saudi Arabia
5.5.7.Rest of LAMEA

CHAPTER 6:COMPANY PROFILES

6.1.ABBOTT LABORATORIES

6.1.1.Company overview
6.1.2.Company snapshot
6.1.3.Operating business segments
6.1.4.Product portfolio
6.1.5.Business performance

6.2.ANGIODYNAMICS, INC.

6.2.1.Company overview
6.2.2.Company snapshot
6.2.3.Operating business segments
6.2.4.Product portfolio
6.2.5.Business performance
6.2.6.Key strategic moves and developments

6.3.B. BRAUN MELSUNGEN AG

6.3.1.Company overview
6.3.2.Company snapshot
6.3.3.Operating business segments
6.3.4.Product portfolio
6.3.5.Business performance

6.4.BIOTRONIK, INC.

6.4.1.Company overview
6.4.2.Company snapshot
6.4.3.Operating business segments
6.4.4.Product portfolio
6.4.5.Key strategic moves and developments

6.5.BOSTON SCIENTIFIC CORPORATION

6.5.1.Company overview
6.5.2.Company snapshot
6.5.3.Operating business segments
6.5.4.Product Portfolio
6.5.5.Business performance

6.6.BECTON, DICKINSON AND COMPANY

6.6.1.Company overview
6.6.2.Company snapshot
6.6.3.Operating business segments
6.6.4.Product portfolio
6.6.5.Business performance
6.6.6.Key strategic moves and developments

6.7.CARDINAL HEALTH, INC.

6.7.1.Company overview
6.7.2.Company snapshot
6.7.3.Operating business segments
6.7.4.Product portfolio
6.7.5.Business performance

6.8.COOK MEDICAL, INC.

6.8.1.Company overview
6.8.2.Company snapshot
6.8.3.Operating business segments
6.8.4.Product portfolio
6.8.5.Key strategic moves and developments

6.9.KONINKLIJKE PHILIPS N.V. (PHILIPS)

6.9.1.Company overview
6.9.2.Company snapshot
6.9.3.Operating business segments
6.9.4.Product portfolio
6.9.5.Business performance
6.9.6.Key strategic moves and developments

6.10.TERUMO CORPORATION

6.10.1.Company overview
6.10.2.Company snapshot
6.10.3.Operating business segments
6.10.4.Product portfolio
6.10.5.Business performance
6.10.6.Key strategic moves and developments

LIST OF TABLES

TABLE 01.GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 02.PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL ANGIOPLASTY BALLOONS, BY REGION, 2019–2027 ($MILLION)
TABLE 03.PERIPHERAL ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 04.PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL STENTS, BY REGION, 2019–2027 ($MILLION)
TABLE 05.PERIPHERAL CATHETERS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 06.PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL CATHETER, BY REGION, 2019–2027 ($MILLION)
TABLE 07.PERIPHERAL CATHETERS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 08.PERIPHERAL ARTERY DISEASE MARKET FOR INFERIOR VENA CAVA (IVC) FILTERS, BY REGION, 2019–2027 ($MILLION)
TABLE 09.INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 10.PERIPHERAL ARTERY DISEASE MARKET FOR PLAQUE MODIFICATION DEVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 11.PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 12.PERIPHERAL ARTERY DISEASE MARKET FOR HEMODYNAMIC FLOW ALTERATION DEVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 13.HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 14.PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL ACCESSORIES, BY REGION, 2019–2027 ($MILLION)
TABLE 15.PERIPHERAL ACCESSORIES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 16.PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 17.NORTH AMERICA PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 18.NORTH AMERICA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 19.U.S. PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 20.CANADA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 21.MEXICO PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 22.EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 23.EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 24.GERMANY PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 25.FRANCE PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 26.UK PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 27.ITALY PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 28.SPAIN PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 29.REST OF EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 30.ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 31.ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 32.JAPAN PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 33.CHINA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 34.INDIA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 35.AUSTRALIA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 36.REST OF ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 37.LAMEA PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 38.LAMEA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 39.BRAZIL PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 40.SOUTH AFRICA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 41.SAUDI ARABIA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 42.REST OF LAMEA PERIPHERAL ARTERY DISEASE MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 43.ABBOTT: COMPANY SNAPSHOT
TABLE 44.ABBOTT: OERATING SEGMENT
TABLE 45.ABBOTT: PRODUCT PORTFOLIO
TABLE 46.ANGIODYNAMICS: COMPANY SNAPSHOT
TABLE 47.ANGIODYNAMICS: OPERATING SEGMENTS
TABLE 48.ANGIODYNAMICS: PRODUCT PORTFOLIO
TABLE 49.B. BRAUN: COMPANY SNAPSHOT
TABLE 50.B. BRAUN: OPERATING SEGMENTS
TABLE 51.B. BRAUN: PRODUCT PORTFOLIO:
TABLE 52.BIOTRONIK, INC..: COMPANY SNAPSHOT
TABLE 53.BIOTRONIK, INC..: OPERATING SEGMENTS
TABLE 54.BIOTRONIK, INC.: PRODUCT PORTFOLIO
TABLE 55.BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 56.BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 57.BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 58.BD: SNAPSHOT
TABLE 59.BD: OPERATING SEGMENTS
TABLE 60.BD: PRODUCT PORTFOLIO
TABLE 61.CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 62.CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 63.CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 64.COOK: COMPANY SNAPSHOT
TABLE 65.COOK: OERATING SEGMENT
TABLE 66.COOK: PRODUCT PORTFOLIO
TABLE 67.PHILIPS: COMPANY SNAPSHOT
TABLE 68.PHILIPS: OPERATING SEGMENTS
TABLE 69.PHILIPS: PRODUCT PORTFOLIO
TABLE 70.TERUMO: COMPANY SNAPSHOT
TABLE 71.TERUMO: OPERATING SEGMENTS
TABLE 72.TERUMO: PRODUCT PORTFOLIO:

LIST OF FIGURES

FIGURE 01.PERIPHERAL ARTERY DISEASE MARKET SEGMENTATION
FIGURE 02.TOP WINNING STRATEGIES, BY DEVELOPMENTS, 2018–2020*
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2020*
FIGURE 04.TOP WINNING STRATEGIES: COMPANY, 2018–2020
FIGURE 05.TOP PLAYER POSITIONING, 2019
FIGURE 06.TOP INVESTMENT POCKETS
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08.HIGH BARGAINING POWER OF BUYERS
FIGURE 09.MODERATE THREAT OF SUBSTITUTES
FIGURE 10.HIGH INTENSITY OF RIVALRY
FIGURE 11.HIGH THREAT OF NEW ENTRANTS
FIGURE 12.IMPACT ANALYSIS, PERIPHERAL ARTERY DISEASE MARKET
FIGURE 13.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL ANGIOPLASTY BALLOONS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 14.GLOBAL OLD/NORMAL BALLOONS MARKET, 2019–2027 ($MILLION)
FIGURE 15.GLOBAL CUTTING & SCORING BALLOONS MARKET, 2019–2027 ($MILLION)
FIGURE 16.GLOBAL DRUG COATED BALLOONS MARKET, 2019–2027 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL STENTS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 18.GLOBAL SELF-EXPANDABLE MARKET, 2019–2027 ($MILLION)
FIGURE 19.GLOBAL BALLOON EXPANDABLE MARKET, 2019–2027 ($MILLION)
FIGURE 20.GLOBAL COVERED STENTS MARKET, 2019–2027 ($MILLION)
FIGURE 21.GLOBAL DRUG-ELUTING STENTS MARKET, 2019–2027 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL CATHETER, BY COUNTRY, 2019 & 2027 (%)
FIGURE 23.GLOBAL ANGIOGRAPHY CATHETERS MARKET, 2019–2027 ($MILLION)
FIGURE 24.GLOBAL GUIDING CATHETERS MARKET, 2019–2027 ($MILLION)
FIGURE 25.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR INFERIOR VENA CAVA (IVC) FILTERS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 26.GLOBAL PERMANENT FILTERS MARKET, 2019–2027 ($MILLION)
FIGURE 27.GLOBAL RETRIEVABLE FILTERS MARKET, 2019–2027 ($MILLION)
FIGURE 28.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PLAQUE MODIFICATION DEVICES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 29.GLOBAL THROMBECTOMY DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 30.GLOBAL THROMBECTOMY DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
FIGURE 31.GLOBAL THROMBECTOMY DEVICES MARKET FOR MECHANICAL THROMBECTOMY DEVICES, BY TYPE 2019–2027 ($MILLION)
FIGURE 32.GLOBAL THROMBECTOMY DEVICES MARKET FOR ASPIRATION THROMBECTOMY DEVICES, BY TYPE 2019–2027 ($MILLION)
FIGURE 33.GLOBAL THROMBECTOMY DEVICES MARKET FOR RHEOLYTIC THROMBECTOMY DEVICES, BY TYPE, 2019–2027 ($MILLION)
FIGURE 34.GLOBAL ATHERECTOMY DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 35.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR HEMODYNAMIC FLOW ALTERATION DEVICES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 36.GLOBAL EMBOLIC PROTECTION DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 37.GLOBAL CHRONIC TOTAL OCCLUSION DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 38.COMPARATIVE ANALYSIS OF PERIPHERAL ARTERY DISEASE MARKET FOR PERIPHERAL ACCESSORIES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 39.GLOBAL PERIPHERAL VASCULAR CLOSURE DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 40.GLOBAL INTRODUCER SHEATHS MARKET, 2019–2027 ($MILLION)
FIGURE 41.GLOBAL GUIDEWIRES MARKET, 2019–2027 ($MILLION)
FIGURE 42.GLOBAL BALLOON INFLATION DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 43.ABBOTT: NET SALES, 2017–2019 ($MILLION)
FIGURE 44.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 45.ABBOTT: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 46.ANGIODYNAMICS: NET SALES, 2017–2019 ($MILLION)
FIGURE 47.ANGIODYNAMICS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 48.ANGIODYNAMICS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 49.B. BRAUN: NET SALES, 2017–2019 ($MILLION)
FIGURE 50.B. BRAUN: REVENUE SHARE, BY SEGMENTS, 2019 (%)
FIGURE 51.B. BRAUN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 52.BOSTON SCIENTIFIC: NET SALES, 2017–2019 ($MILLION)
FIGURE 53.BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2019 (%)
FIGURE 54.BOSTON SCIENTIFIC: NET SALES, BY REGION, 2019 (%)
FIGURE 55.BD: NET SALES, 2017–2019 ($MILLION)
FIGURE 56.BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 57.BECTON, DICKINSON AND COMPANY REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 58.CARDINAL HEALTH: NET SALES, 2017–2019 ($MILLION)
FIGURE 59.CARDINAL HEALTH: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 60.CARDINAL HEALTH: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 61.PHILIPS: NET SALES, 2017–2019 ($MILLION)
FIGURE 62.PHILIPS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 63.PHILIPS: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 64.TERUMO CORPORATION: NET SALES, 2016–2018 ($MILLION)
FIGURE 65.TERUMO: REVENUE SHARE, BY SEGMENTS, 2018(%)
FIGURE 66.TERUMO: REVENUE SHARE, BY REGION, 2018 (%)

 
 

This section provides various opinions of top-level CXOs in the peripheral artery diseases market. According to CXOs, adoption of peripheral artery diseases is expected to increase, owing to increase in prevalence of diabetes, cardiac disease, rise in geriatric population, and growth in demand for PAD devices fuels the market growth. In addition, players operating in the global peripheral artery disease market are focusing on product launches, approvals, and partnerships to gain market dominance and keep their products updated and in demand. For instance, Ra Medical Systems, makers of excimer lasers and catheters for cardiovascular and dermatological diseases received market clearance from FDA in 2017 for its DABRA System. This system clears blockage and removes plaque from arteries. It is a faster and less-expensive solution as compared to other treatments. In addition, constantly changing lifestyle habits such as unhealthy dietary habits, excessive alcohol consumption, smoking, obesity, and lack of physical activity make individuals more susceptible to peripheral artery diseases, which drives the market growth.

North America is expected to dominate the global peripheral artery disease market in the future, followed by Europe. Moreover, Asia-Pacific is expected to represent the highest market growth potential during the forecast period due to the growing patient pool and increasing technological advancements. The fast growth of Asia-Pacific is attributed to the increase in per capita income along with government initiatives to enhance quality of healthcare and rise in diabetes is the major concern in this region. China, India, and Australia have a lucrative market for peripheral artery disease, owing to growing older population. In addition, PAD device manufacturers and distributors focus to expand their presence in emerging economies to increase their market outreach. A rapid growth was observed in shipments of these devices by key manufacturers to improve obstetrics and healthcare services in emerging nations. This trend is expected to offset challenging conditions in mature markets such as North America and Europe.


 

 

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library,  T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
 

A. The total market value of peripheral artery disease market is $3,524.77 million in 2019.

A. The forcast period for peripheral artery disease market is 2020 to 2027

A. The market value of peripheral artery disease market in 2027 is $ 5,715.12 million.

A. The base year is 2019 in peripheral artery disease market

A. Top companies such as Koninklijke Philips N.V., ABBOTT LABORATORIES, Cook Medical LLC, Becton, Dickinson and Company, and Terumo Corporation held a high market position in 2019. These key players held a high market postion owing to the strong geographical foothold in different regions.

A. In type segment plaque modification devices is the most influencing segment. Increase in incidences of plaque buildup in peripheral arteries is the major factor that drives the market. In addition, these devices are extremely useful when ballooning of arteries fail, hence it becomes a necessity to use plaque modification devices.

A. The major factor that fuels the growth of the global peripheral artery disease market includes growth in geriatric population and increase in prevalence of peripheral artery disease, advanced interventional products, improvement of healthcare infrastructure in developing countries. This leads to surge in demand for peripheral artery disease devices which contribute to the growth of the market.

A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the emerging countries. This is due to improvement in health awareness, development in healthcare infrastructure, and rise in number of hospitals equipped with advanced medical facilities.

A. Peripheral artery disease (PAD) is a disease of blood vessels located outside the brain and heart. PAD occurs when plaque builds up in arteries that carry blood to the head, organs, and limbs.

A. Increase in number of aging populations worldwide and and increase in incidences of disorders such as diabetes and hypertension, which, in turn, increases the risk for peripheral artery diseases.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Peripheral Artery Disease Market

  • Online Only
  • $3,713
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,126
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,169
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,930
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,665
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library.  T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts